Public Speaker Characteristics at Meetings of the Dermatologic and Ophthalmic Drug Advisory Committee and the Ophthalmic Devices Panel

We investigated meetings of the Dermatologic and Ophthalmic Drug Advisory Committee (DODAC) and the Ophthalmic Devices Panel (ODP) of the Food and Drug Administration (FDA) to determine whether a relationship exists between receipt of industry payments by speakers of the Open Public Hearing (OPH) portion and the nature of their recommendations regarding treatment approval.

Source: American Journal of Ophthalmology - November 6, 2020 Category: Opthalmology Authors: Mostafa H. Khattab, Michael Weaver, Courtney Cook, Nicholas Kinder, Matt Vassar Tags: Original Articles Source Type: research